Financials
- Market Capitalization 53.04 M
- Employee 17
- Founded 2018
- CEO N/A
- Website www.instilbio.com
- Headquarter New York, United States
- FIGI BBG00ZGYN521
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.18
ratio cours/chiffre d'affaires
6.16
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4253 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | 0.00% | -18.90% | -17.39% | -41.41% | 54.69 M USD | ||
| 4261 | INMB INmune Bio Inc. - Common stock | 2.02 USD | +8.60% | +16.09% | +56.59% | -1.94% | 53.70 M USD | ||
| 4272 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.03 USD | -2.27% | -1.20% | +6.24% | +1136.99% | 52.22 M USD | ||
| 4279 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.34 USD | -4.98% | -32.49% | -5.32% | -35.12% | 51.19 M USD |